Recent Advances in Adipokines (3nd Edition)

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".

Deadline for manuscript submissions: 28 February 2026 | Viewed by 898

Special Issue Editor

Special Issue Information

Dear Colleagues,

This Special Issue, “Recent Advances in Adipokines (3nd Edition)”, will cover a selection of original research articles and review articles related to adipokines.

Soluble proteins produced from adipose tissue are referred to as adipokines irrespective of their cellular source. White fat tissue is organized into different depots in the body. Subcutaneous and visceral adipose tissues are the best-studied compartments. Adipose tissues are also localized around organs, such as the heart and kidneys. Brown adipose tissue differs greatly from white fat and has its own set of secreted hormones, the so-called “brown adipokines”.

To date, more than 500 adipokines have been described, and most of them are associated with overweight/obesity. Whilst levels of various adipokines are increased in the serum of the obese, others decline. Associations between adipokines and cardiovascular diseases, insulin resistance, different types of cancers, and many more diseases have been identified. Further research has focused on the role of these proteins in immune responses, in autoimmune diseases, and as antimicrobial peptides. Adipokines in serum, plasma, saliva, or urine may emerge as diagnostic and/or prognostic biomarkers for various diseases.

Adipokine receptors are mostly not well characterized. Cell type and tissue expression, regulation using different metabolites, and signalling pathways have to be studied in more detail. Adipokine receptor agonists/antagonists may finally become new therapeutic targets.

Prof. Dr. Christa Büchler
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • adiponectin
  • receptor
  • agonist
  • biomarker
  • inflammation
  • cancer

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 1733 KB  
Article
Resistin as Modulator of Functional Activity of Phagocytes in Colostrum and Blood of Overweight and Obese Mothers
by Carla Roberta Silva Souza Antônio, Elisia Possidônea Pereira, Danielle Cristina Honorio França, Patricia Gelli Feres de Marchi, Emanuelle Carolina Honorio França, Anibal Monteiro de Magalhães Neto, Elton Brito Ribeiro, Danny Laura Gomes Fagundes-Triches, Adenilda Cristina Honorio-França and Eduardo Luzía França
Biomedicines 2025, 13(11), 2815; https://doi.org/10.3390/biomedicines13112815 - 18 Nov 2025
Viewed by 333
Abstract
Background/Objectives: Resistin is an adipokine involved in obesity pathogenesis, but its effects on blood and colostrum immune cells from obese mothers remain unclear. This study evaluated the functional activity of phagocytes modulated by resistin in blood and colostrum from overweight and obese [...] Read more.
Background/Objectives: Resistin is an adipokine involved in obesity pathogenesis, but its effects on blood and colostrum immune cells from obese mothers remain unclear. This study evaluated the functional activity of phagocytes modulated by resistin in blood and colostrum from overweight and obese mothers. Methods: An observational study was conducted with 82 postpartum women divided according to pregestational BMI into control, overweight, and obese groups. Blood and colostrum samples were collected to determine resistin levels and assess the functional activity of mononuclear (MN) cells. Results: Plasma resistin levels were higher in overweight mothers, whereas colostrum levels were lower in obese mothers. Resistin treatment enhanced superoxide release in both colostrum and blood phagocytes, independent of maternal weight status. In the presence of enteropathogenic Escherichia coli (EPEC), resistin-treated phagocytes from both colostrum and maternal blood showed increased superoxide production. In blood cells from overweight mothers, resistin reduced superoxide dismutase (SOD) concentration, while in colostrum, the highest SOD levels were observed in cultures of resistin-treated cells from mothers with altered weight, regardless of weight status. Blood and colostrum cells treated with resistin increased phagocytosis rates. In colostrum, resistin-treated cells from eutrophic mothers showed high microbicidal indices, whereas cells from mothers with altered weight showed reduced microbicidal indices. In colostrum cells, adipokine levels were reduced in the obesity group. Conclusions: Resistin modulates oxidative metabolism and the functional activity of blood and colostrum phagocytes across all maternal weight statuses, suggesting a possible role for resistin in the maternal immune response associated with obesity. Full article
(This article belongs to the Special Issue Recent Advances in Adipokines (3nd Edition))
Show Figures

Figure 1

Back to TopTop